Dr. Robert John Caldas, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Dr. Debby Almeida, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Dr. Ryan Gates, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Dr. David R Clark, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Kimberly Lewis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Achilles Romualdo E Alcaraz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Eleni Rethimiotakis, MD Family Medicine - Adult Medicine Medicare: Not Enrolled in Medicare Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Stephen Russell Butler, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 39 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3311 Fax: 508-997-5352 |
Dr. Ashley Vertente, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 Fax: 508-961-0949 |
Michelle Mckenney, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Dr. Charles J Gormley Ii, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Dr. John W Bender, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Aileen Caceres Souza, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 535 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Pamela Coury, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Dr. Justin David Etter, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 Fax: 508-961-2993 |
Nicholas Defusco, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Chad Beattie, M.D. Family Medicine - Sports Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 Fax: 508-990-3218 |
Dr. Elaine Wu, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
Gisele Yadje Choo Arrey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 Fax: 508-961-0949 |
Dr. Alexandra Sophocles Ruggiero, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 531 Faunce Corner Rd, Dartmouth, MA 02747 Phone: 508-996-3991 |
News Archive
Since the onset of the CRISPR genetic editing revolution, scientists have been working to leverage the technology in the development of gene drives that target pathogen-spreading mosquitoes such as Anopheles and Aedes species, which spread malaria, dengue and other life-threatening diseases.
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company developing targeted antigen-specific immune therapies for rare and serious diseases, announced today that Nature Nanotechnology has published an article that presents preclinical results from Selecta's research which demonstrate the broad potential applicability of Selecta's novel immune tolerance platform.
TissueGene, Inc. today reported that the U.S. Food and Drug Administration (FDA) accepted the proposed brand name Invossa for TissueGene-C, the Company's proprietary product in development for treatment of osteoarthritis of the knee. FDA's acceptance of the proprietary brand name is subject to the Agency's final determination prior to any approval of the product's Biologic License Application (BLA) and market launch.
In a communication paper recently published in the Journal of Paediatrics and Child Health by Koirala et al. (June 8th, 2021), it is argued that Australian schools should remain open, with proper testing, tracing, and quarantine protocols in place.
› Verified 9 days ago